secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001099800-24-000082
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards completes $4.2B sale of Critical Care to BD, adds $1.5B buyback
-----------------------------------------------------------------------

- Closed all-cash sale of Critical Care to BD (NYSE: BDX) for $4.2B.
- Board authorized additional $1.5B share repurchase; entered $500M accelerated repurchase.
- Total $1B repurchased to date including prior $500M 10b5-1 and open-market buys.
- Net proceeds to fund strategic initiatives, prior acquisitions, and share repurchases.
- Company to discuss strategy and outlook at Wells Fargo Healthcare Conference on Sept 5.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000082/0001099800-24-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980024000082/ew-20240903.htm
  HTML page:      https://secwatch.observer/filing/0001099800-24-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer